Charriol celebrates ‘crazy love’ with new line

The bangles are made of twisted steel cable, which is emblematic of the Charriol brand.
Updated 12 February 2019
0

Charriol celebrates ‘crazy love’ with new line

Swiss watchmaker and jeweler Charriol has launched a new feminine collection — “Crazy in Love Again” — for 2019.

It features a line of jewels that pays tribute to the “passionate, daring and plural femininity,” which is at the heart of the jewelry creations of the brand since 1983. 

Dedicated to “The Art of living the difference,” the collection consists of rings, bracelets, necklaces and earrings, combining white topaz, rhodium silver 925 and steel cables. 

It is for the “eternal and contemporary lovers” to express to their partner how much they are “Crazy in Love Again” on this Feb. 14. The theme of love is expressed through the ballet of the heart and the arrow, in a jewelry line that plays with symmetry and asymmetry.

“The bangles, made of twisted steel cable, emblematic of the brand Charriol, come here to offer their strands of masculinity to ultra-feminine jewelry that wrap around wrists and punctuate them with hearts and arrows set with white topaz,” Charriol said. 

The collection consists of two models of finger rings made in twisted steel and white topaz.

“In the Crazy in Love Again collection, the earrings unveil a new spirit of modernity with elegance and glamor. Models play asymmetry. Each loop is unique. A mesh pendant echoes a nail or embellishes a pair of heart and arrow that frame the face,” the brand said.

The necklaces of the line feature fluid silver chains with asymmetrical and elaborate meshes, extended with crimped pendants and lariats without a clasp or a fastener, whose chains decorated with charms pass through a ring to seal the necklace.


Pharmaceutical giant Allergan to train KSU pharmacy students

Updated 23 April 2019
0

Pharmaceutical giant Allergan to train KSU pharmacy students

Global biopharmaceutical company Allergan has signed a memorandum of understanding (MoU) with King Saud University (KSU) that focuses on developing a robust student-exchange program by facilitating training opportunities for Saudi nationals.

The agreement was signed by Ramsey Morad, Allergan’s vice president for India, Middle East and Africa, and Dr. Aws Al-Shamsan, dean of the College of Pharmacy at the university. The MoU is in line with the Kingdom’s overall efforts to drive more cooperation levels between the public and private sectors, with the underlying objective to integrate Saudi nationals into various fields within the health-care sector.

Under the agreement, Allergan will provide training courses on an annual basis for students at the College of Pharmacy as well as programs to develop their scientific and medical knowledge and align them to international industry best practices. Students will be assessed according to set parameters, and the top performers will earn an internship opportunity with the company

In addition, Allergan will run courses for faculty members at the College of Pharmacy with a focus on leadership skills.

Morad said: “We have used practical methods to express our commitment toward the Kingdom and toward the realization of Vision 2030. We are placing a very high emphasis on developing the local capabilities of Saudi nationals within the health-care sector, and this partnership with a leading university in the region is one of the steps we are taking. Saudi Arabia is at the heart of our operations in the region, and this MoU represents a key milestone in our efforts to attract the young minds of tomorrow and integrate them as core members of our Allergan team.” 

Al-Shamsan said: “We are proud to partner with Allergan to implement internationally recognized knowledge-based programs for the development of our students. With this MoU, we are focusing on the enhancement and development of the pharmaceutical sector across the Kingdom. We are guided by the mission to provide students experiences to learn from international best practices and, at the same time, work toward the improvement of the quality of the pharmaceutical sector in the Kingdom.”

Allergan said it is committed to a wide range of programs with health-care professionals, patients and national entities across the Kingdom. The company’s investments through its joint venture, Allergan Saudi Arabia, include the development of medical training centers focused on training health-care professionals in medical aesthetics.